Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually) to review information presented at ASCO and ESMO for 2021.

For this series, the doctors discuss new trials for patients with NSCLC. The doctors discuss CheckMate 816, the addition of Nivolumab as neoadjuvant therapy in Early Stage NSCLC.

For more, please visit [ Ссылка ]. To join the conversation, visit [ Ссылка ].

свернуть